We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCKY icon
951
Rocky Brands
RCKY
$369M
$224K ﹤0.01%
7,595
+6,215
+450% +$183K
WTRE
952
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$223K ﹤0.01%
8,850
+4,498
+103% +$120K
GBT
953
DELISTED
Global Blood Therapeutics, Inc.
GBT
$221K ﹤0.01%
2,776
-5,014
-64% -$297K
EQX icon
954
Equinox Gold
EQX
$13.5B
$220K ﹤0.01%
+28,635
New +$177K
GATX icon
955
GATX Corp
GATX
$6.27B
$220K ﹤0.01%
2,665
-1,085
-29% -$87.3K
PLUG icon
956
Plug Power
PLUG
$3.04B
$220K ﹤0.01%
+69,673
New +$212K
CORT icon
957
Corcept Therapeutics
CORT
$12B
$217K ﹤0.01%
+17,980
New +$250K
EAF icon
958
GrafTech
EAF
$212M
$217K ﹤0.01%
1,867
-42,010
-96% -$5.28M
TWST icon
959
Twist Bioscience
TWST
$7.25B
$215K ﹤0.01%
+10,243
New +$240K
LHCG
960
DELISTED
LHC Group LLC
LHCG
$215K ﹤0.01%
+1,565
New +$195K
ZUMZ icon
961
Zumiez
ZUMZ
$339M
$214K ﹤0.01%
6,207
-61,121
-91% -$1.93M
AYI icon
962
Acuity Brands
AYI
$10.8B
$213K ﹤0.01%
+1,536
New +$197K
MIXT
963
DELISTED
MIX TELEMATICS LIMITED
MIXT
$213K ﹤0.01%
16,423
-27,267
-62% -$345K
HCCI
964
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$208K ﹤0.01%
+6,626
New +$190K
SHOO icon
965
Steven Madden
SHOO
$3.55B
$205K ﹤0.01%
+4,773
New +$193K
QTNT
966
DELISTED
Quotient Limited Ordinary Shares
QTNT
$203K ﹤0.01%
535
-558
-51% -$185K
CDZI icon
967
Cadiz
CDZI
$291M
$202K ﹤0.01%
+18,288
New +$211K
NTGR icon
968
NETGEAR
NTGR
$635M
$200K ﹤0.01%
8,174
+5,911
+261% +$162K
CWST icon
969
Casella Waste Systems
CWST
$5.69B
$198K ﹤0.01%
+4,295
New +$189K
XENE icon
970
Xenon Pharmaceuticals
XENE
$6.12B
$196K ﹤0.01%
+14,939
New +$157K
CNR
971
Core Natural Resources Inc
CNR
$4.45B
$196K ﹤0.01%
13,503
-14,136
-51% -$195K
LGF.A
972
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$196K ﹤0.01%
+18,371
New +$169K
AMWD
973
DELISTED
American Woodmark
AMWD
$195K ﹤0.01%
1,865
-103,641
-98% -$10.4M
MYRG icon
974
MYR Group
MYRG
$5.25B
$195K ﹤0.01%
5,986
-2,479
-29% -$81.8K
MMYT icon
975
MakeMyTrip
MMYT
$5.64B
$192K ﹤0.01%
+8,393
New +$203K
37 38
39
40 41

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.